Biomarker selection of liver metastatic colorectal patients for anti-EGFR monoclonal antibodies: A machine learning analysis

被引:0
|
作者
Chen, Y. [1 ,2 ]
Chang, W. [1 ,2 ]
Wei, Y. [1 ,2 ]
Xu, J. [3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Colorectal Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Gen Surg, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
93P
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
    Yuan, Zi-Xu
    Wang, Xiao-Yan
    Qin, Qi-Yuan
    Chen, De-Feng
    Zhong, Qing-Hua
    Wang, Lei
    Wang, Jian-Ping
    PLOS ONE, 2013, 8 (06):
  • [22] Beyond KRAS:Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    Alfonso De Stefano
    Chiara Carlomagno
    World Journal of Gastroenterology, 2014, (29) : 9732 - 9743
  • [23] Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    De Stefano, Alfonso
    Carlomagno, Chiara
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 9732 - 9743
  • [24] Anti-VEGF and Anti-EGFR Monoclonal Antibodies in the First-line Therapy for Metastatic Colorectal Cancer - A Meta-Analysis
    Zhou, Zheng
    Walsh, William V.
    Bathini, Venu G.
    Piperdi, Bilal
    CURRENT CANCER THERAPY REVIEWS, 2011, 7 (04) : 282 - 289
  • [25] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Mao, Chen
    Liao, Ru-Yan
    Qiu, Li-Xin
    Wang, Xi-Wen
    Ding, Hong
    Chen, Qing
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (04) : 2219 - 2223
  • [26] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Chen Mao
    Ru-Yan Liao
    Li-Xin Qiu
    Xi-Wen Wang
    Hong Ding
    Qing Chen
    Molecular Biology Reports, 2011, 38 : 2219 - 2223
  • [27] Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
    Morelli, M. Pia
    Overman, Michael J.
    Dasari, Arvind
    Kazmi, Syed Mohammad Ali
    Sanchez, Eduardo Vilar
    Eng, Cathy
    Kee, Bryan K.
    Deaton, Laurel
    Garrett, Chris R.
    Diehl, Frank
    Angenendt, Philipp
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
    Rachiglio, Anna Maria
    Forgione, Laura
    Pasquale, Raffaella
    Barone, Carlo Antonio
    Maiello, Evaristo
    Antonuzzo, Lorenzo
    Cassata, Antonino
    Tonini, Giuseppe
    Bordonaro, Roberto
    Rosati, Gerardo
    Zaniboni, Alberto
    Lonardi, Sara
    Ferrari, Daris
    Frassineti, Giovanni Luca
    Tamberi, Stefano
    Pisconti, Salvatore
    Di Fabio, Francesca
    Roma, Cristin
    Orlandi, Armando
    Latiano, Tiziana
    Damato, Angela
    Tortora, Giampaolo
    Pinto, Carmine
    Normanno, Nicola
    CANCERS, 2022, 14 (04)
  • [29] SKIN RASH AND OUTCOME IN COLORECTAL CANCER (CRC) PATIENTS TREATED WITH ANTI-EGFR MONOCLONAL ANTIBODIES
    Petrelli, F.
    Borgonovo, K. F.
    Cabiddu, M.
    Ghilardi, M.
    Cremonesi, M.
    Maspero, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 192 - 192
  • [30] Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
    Ciardiello, Davide
    Martini, Giulia
    Famiglietti, Vincenzo
    Napolitano, Stefania
    De Falco, Vincenzo
    Troiani, Teresa
    Latiano, Tiziana Pia
    Ros, Javier
    Elez Fernandez, Elena
    Vitiello, Pietro Paolo
    Maiello, Evaristo
    Ciardiello, Fortunato
    Martinelli, Erika
    CANCERS, 2021, 13 (08)